topic0
Risk Factors [qnco] 0.0116264215846
Study [mnob] 0.00994509306559
YEARS [tmco] 0.00949369765937
HEPATITIS C VIRUS [virs] 0.00899794926558
CIRRHOSIS [dsyn] 0.00826636617671
Survival [acty] 0.00680169895241
LIVER [bpoc] 0.00652155998533
Related [qlco] 0.00644619584736
Chronic hepatitis C [dsyn] 0.0060013027421
Hepatitis C virus infection [dsyn] 0.00542813349112
lesions [fndg] 0.00540393493441
Methods [inpr] 0.0053221752596
treatment [ftcn] 0.00528117084596
Group [idcn] 0.0050099618998
Compared [acty] 0.00473580657773
Cases [ftcn] 0.00452015185495
resection [topp] 0.00404152586406
Radiofrequency Ablation [topp] 0.00399487765642
YEAR [tmco] 0.0037585863882
Hepatic [blor] 0.00370613302225
Hepatectomy [topp] 0.0037042480912
Levels [qlco] 0.00356363521345
HEPATITIS B VIRUS [virs] 0.00339267135001
Tumour NOS [neop] 0.00325126830225
Greater [qnco] 0.00322213167926
TYPE [qlco] 0.00321328521791
Increased [qnco] 0.00319806714714
included [ftcn] 0.00305975398634
Treated [ftcn] 0.00300718282445
Morbidity [qnco] 0.00295044752123
Low [qlco] 0.00284431316974
Women [popg] 0.00276781380167
Conclusions [idcn] 0.00273460007817
Postoperative [tmco] 0.00270700855768
control [qlco] 0.00270267290559
LOCAL [spco] 0.00268076046171
Men [popg] 0.0026163670438
occurrence [ftcn] 0.00259513469873
Mortality [qnco] 0.00259004232868
CI [geoa] 0.00256135891027
topic1
LIVER [bpoc] 0.013400013836
Survival [acty] 0.0106509932938
CIRRHOSIS [dsyn] 0.0101310928708
resection [topp] 0.00966564181693
YEARS [tmco] 0.00964567492345
Study [mnob] 0.00910080164583
Methods [inpr] 0.00708476727811
Group [idcn] 0.00668521120091
HEPATITIS C VIRUS [virs] 0.00655543774544
Tumour NOS [neop] 0.00648725083283
Compared [acty] 0.00643980476673
Mortality [qnco] 0.00569270874227
Conclusions [idcn] 0.00530977557505
Hepatic [blor] 0.00521965443286
Related [qlco] 0.00504547050667
Risk Factors [qnco] 0.00491010453478
Subject [grup] 0.00490781730134
Radiofrequency Ablation [topp] 0.00475313862323
Independent [idcn] 0.00468013125686
treatment [ftcn] 0.00434884579894
YEAR [tmco] 0.00428141912259
Increased [qnco] 0.00407291139253
control [qlco] 0.00402722316932
Cirrhotic [qlco] 0.00389015795472
Levels [qlco] 0.00381037547598
Performed [ftcn] 0.00365390076091
Cases [ftcn] 0.00350329091115
LIVER DISEASE [dsyn] 0.00340816770536
Human [humn] 0.00325843769997
Higher [qlco] 0.00322217987186
Equal [qlco] 0.00322013777598
HEPATITIS B VIRUS [virs] 0.00320428448098
Median [spco] 0.00311801916343
Observed [ftcn] 0.00311726204838
LIVER CIRRHOSIS [dsyn] 0.00306296772874
Tumors [neop] 0.00304387365504
Suggest [idcn] 0.00282395083002
DIABETES MELLITUS [dsyn] 0.00274592097024
Long Term [tmco] 0.00265840630672
HCC [neop] 0.00262167572499
topic2
Cases [ftcn] 0.0137566298388
HEPATITIS C VIRUS [virs] 0.00824470111408
Study [mnob] 0.00744099186816
treatment [ftcn] 0.00728735737695
LIVER [bpoc] 0.00691423967531
resection [topp] 0.00661762434936
CIRRHOSIS [dsyn] 0.00651873945604
Hepatic [blor] 0.00569720867345
Risk Factors [qnco] 0.00533188497902
Related [qlco] 0.0044356480902
Methods [inpr] 0.00439194974607
YEAR [tmco] 0.00429508266233
Tumour NOS [neop] 0.00408123801648
HCV [virs] 0.00407055793544
Hepatitis C virus infection [dsyn] 0.00406575787276
YEARS [tmco] 0.00395325355233
lesions [fndg] 0.00395258420394
HEPATITIS B VIRUS [virs] 0.0037623351013
Less [qnco] 0.00370488391975
Hepatocellular Carcinomas [neop] 0.00367941464232
Group [idcn] 0.00347302054707
Viral [ftcn] 0.00345904384024
Survival [acty] 0.00336864667091
Pathology [bmod] 0.00326998828512
tumor recurrence [neop] 0.00324345229814
Five [qnco] 0.00318127094038
Cirrhotic [qlco] 0.00311501682547
etiology [ftcn] 0.00301992747692
Postoperative [tmco] 0.00300230857974
Tumors [neop] 0.00297430166977
FIBROSIS [patf] 0.00286117091706
Range [qnco] 0.00278933648483
included [ftcn] 0.00275952011927
Nodules [acab] 0.00269891909213
Mortality [qnco] 0.00266852788889
Complication [patf] 0.00265497026235
therapy [ftcn] 0.00261489054918
Progression [patf] 0.00259766737828
Conclusions [idcn] 0.00251897604693
Compared [acty] 0.00250017477287
topic3
Risk Factors [qnco] 0.00738323192886
CIRRHOSIS [dsyn] 0.00716480995435
Group [idcn] 0.00647436087853
HEPATITIS C VIRUS [virs] 0.00550971617978
Hepatectomy [topp] 0.00542665954779
YEARS [tmco] 0.00540526080952
Cases [ftcn] 0.00533908699196
Hepatitis C virus infection [dsyn] 0.00507859144783
resection [topp] 0.0049734772746
Study [mnob] 0.00490475460957
Mortality [qnco] 0.0047455935613
HCV [virs] 0.00460661084329
Cholangiocarcinoma [neop] 0.0040533761328
Postoperative [tmco] 0.00393698795582
Tumour NOS [neop] 0.00392510974762
Related [qlco] 0.00388096359308
Methods [inpr] 0.00378960305221
DIAGNOSIS [fndg] 0.00337930279007
YEAR [tmco] 0.00333091646028
Response [orga] 0.00332387612683
Survival [acty] 0.00317067603543
LIVER [bpoc] 0.00311868986462
Hepatic [blor] 0.00311630290736
Performed [ftcn] 0.0029051569235
Identified [qlco] 0.00284423585997
Pathology [bmod] 0.00277737829612
Tumors [neop] 0.00272736058728
included [ftcn] 0.00272139200694
Negative [qlco] 0.00270291715521
Morbidity [qnco] 0.00264863079381
Higher [qlco] 0.00262613361727
HEPATITIS B VIRUS [virs] 0.00254167433058
Detected [fndg] 0.00245307023507
CANCER [neop] 0.00245003078507
Compared [acty] 0.00241908619958
LIVER CIRRHOSIS [dsyn] 0.00240816558595
Low [qlco] 0.00238938462222
Nonalcoholic Fatty Liver Disease [dsyn] 0.00233236645664
Hepatocellular Carcinomas [neop] 0.00233187645405
Long Term [tmco] 0.00233048124985
topic4
Cases [ftcn] 0.0121169024142
HEPATITIS B VIRUS [virs] 0.00987983904801
Tumour NOS [neop] 0.00654572335947
LIVER [bpoc] 0.00597539406312
Related [qlco] 0.00567135253495
YEARS [tmco] 0.00550112183525
Risk Factors [qnco] 0.00529589006385
Increased [qnco] 0.00501912144532
HEPATITIS C VIRUS [virs] 0.00489107233339
Mortality [qnco] 0.00485271046931
Study [mnob] 0.00481440215421
Cholangiocarcinoma [neop] 0.00475281121277
Tumors [neop] 0.00416854822063
Liver Cancer [neop] 0.00413038801676
Survival [acty] 0.0041224752417
Conclusions [idcn] 0.00401789633116
Compared [acty] 0.00399968837503
Nodules [acab] 0.00383150025333
Methods [inpr] 0.00373700352025
LOWER [spco] 0.00363090956193
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.0036115468798
HCC [neop] 0.00343823377788
Liver Transplantation [topp] 0.00332762893965
CIRRHOSIS [dsyn] 0.00325586176061
treatment [ftcn] 0.00319468560359
Higher [qlco] 0.00316730639728
findings [ftcn] 0.00304121138495
Based [ftcn] 0.00303463745163
Cancers [neop] 0.0030064953452
Suggest [idcn] 0.00283990894536
resection [topp] 0.00280733507087
Correlation [qlco] 0.00265367959948
Gall Bladder [bpoc] 0.00259006844946
control [qlco] 0.0025580091873
Pathology [bmod] 0.00248439471004
SMALL [qnco] 0.00247517922515
Detected [fndg] 0.00245962679968
CANCER [neop] 0.00244757400696
Diagnosed [fndg] 0.0024050863886
Identified [qlco] 0.00233987703622
topic5
Risk Factors [qnco] 0.011628265023
Cases [ftcn] 0.00924471588196
Tumour NOS [neop] 0.00765873921811
Study [mnob] 0.00733432890986
YEARS [tmco] 0.00703248771751
LIVER [bpoc] 0.00689369283488
Group [idcn] 0.00655044350412
HEPATITIS C VIRUS [virs] 0.00635537561198
Including [ftcn] 0.00525515511713
HCV [virs] 0.00508176320524
Cholangiocarcinoma [neop] 0.00463254459809
Suggest [idcn] 0.00452930319152
CIRRHOSIS [dsyn] 0.00444128227605
YEAR [tmco] 0.00431481423483
therapy [ftcn] 0.00427545700915
control [qlco] 0.00426801373753
HEPATITIS B VIRUS [virs] 0.00413684875577
resection [topp] 0.00405617739312
treatment [ftcn] 0.00400361752763
Intrahepatic [spco] 0.00398858141411
Methods [inpr] 0.00374305361004
Survival [acty] 0.00350009225847
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00349271926508
Compared [acty] 0.00342783449152
Genes [gngm] 0.00321557002564
Molecular [qlco] 0.00320293772805
Based [ftcn] 0.00299581214279
TYPE [qlco] 0.00296775361975
Hepatic [blor] 0.00281111836375
Related [qlco] 0.00280495826899
LIVER CIRRHOSIS [dsyn] 0.00276001964835
Reserve [acty] 0.00272828728504
Groups [idcn] 0.00272201936867
CANCER [neop] 0.00268765754255
Conclusions [idcn] 0.00264705707415
Hepatectomy [topp] 0.00263555814624
DIAGNOSIS [fndg] 0.00258018325978
Higher [qlco] 0.00254449204619
lesions [fndg] 0.00252787519337
Hepatitis C [dsyn] 0.00249689738752
topic6
Risk Factors [qnco] 0.00927603918069
treatment [ftcn] 0.0090921781564
resection [topp] 0.0082876747197
Study [mnob] 0.0082391767306
YEARS [tmco] 0.00809128265939
Cholangiocarcinoma [neop] 0.00685916649286
YEAR [tmco] 0.00669552141712
Group [idcn] 0.00572492967587
LIVER [bpoc] 0.00564348134785
Hepatic [blor] 0.00518208587718
Cases [ftcn] 0.005023525125
DIAGNOSIS [fndg] 0.00431887905151
Increased [qnco] 0.00404331868391
Liver Transplantation [topp] 0.00401549160948
CIRRHOSIS [dsyn] 0.0039218970711
Survival [acty] 0.00360352212005
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00354615141561
Present [qnco] 0.0031909919856
Methods [inpr] 0.0031775388713
Including [ftcn] 0.00312083212358
HEPATITIS C VIRUS [virs] 0.00311515471738
Tumour NOS [neop] 0.00306615622203
Identified [qlco] 0.00299238766206
Screening [hlca] 0.00294636835333
Performed [ftcn] 0.00287283656843
Conclusions [idcn] 0.00281172962858
cholangeitis [dsyn] 0.00279254793689
Mortality [qnco] 0.00274615123071
Postoperative [tmco] 0.0027145749391
Tumors [neop] 0.00267745678955
lesions [fndg] 0.00262746520193
Important [qlco] 0.00261049748545
Transplantation [topp] 0.00254908475424
Pathology [bmod] 0.00251588330543
HEPATITIS B VIRUS [virs] 0.00249300507771
Evaluated [hlca] 0.00246558584852
Related [qlco] 0.00244008019491
Groups [idcn] 0.00241091677427
Greater [qnco] 0.00237189912441
Compared [acty] 0.00234921620371
topic7
Hepatic [blor] 0.0115820345989
LIVER [bpoc] 0.00958506026158
Study [mnob] 0.00872105793395
CIRRHOSIS [dsyn] 0.00721166362381
Risk Factors [qnco] 0.00717879417215
resection [topp] 0.00600381563347
Methods [inpr] 0.00470096809147
HEPATITIS C VIRUS [virs] 0.00468584226079
Cases [ftcn] 0.00449865992649
lesions [fndg] 0.00443158741648
Performed [ftcn] 0.00439066654461
FIBROSIS [patf] 0.0042291077288
HEPATITIS B VIRUS [virs] 0.00408320571068
YEARS [tmco] 0.00402324367495
Hepatitis C virus infection [dsyn] 0.00402068084505
treatment [ftcn] 0.00388719274926
Tumors [neop] 0.00379544097517
Group [idcn] 0.0037517000651
Related [qlco] 0.00370618622835
Intrahepatic Cholangiocarcinoma [neop] 0.00363364676322
Conclusions [idcn] 0.00351815878273
Progression [patf] 0.00341847108679
Compared [acty] 0.00341759982573
Nonalcoholic Fatty Liver Disease [dsyn] 0.00341535815667
Pathology [bmod] 0.0034096117174
Important [qlco] 0.00336950379035
LIVER CIRRHOSIS [dsyn] 0.00335222518472
Survival [acty] 0.00324930672217
Increased [qnco] 0.00319973882826
Cirrhotic [qlco] 0.00318280077214
Suggest [idcn] 0.00312822060276
LIVER DISEASE [dsyn] 0.00299629774502
Infected [fndg] 0.00294562373963
Odds Ratio [qnco] 0.00291174612679
Children [aggp] 0.00286639764129
Treated [ftcn] 0.00278204773821
DIAGNOSIS [fndg] 0.0027133916603
Identified [qlco] 0.00266668533335
Human [humn] 0.0026169406903
Independent [idcn] 0.00255318899512
topic8
Study [mnob] 0.00777980872758
Risk Factors [qnco] 0.00753001195186
HEPATITIS C VIRUS [virs] 0.00693105480812
Methods [inpr] 0.00587259504353
LIVER [bpoc] 0.0058462823145
Tumour NOS [neop] 0.00483022067704
Cholangiocarcinoma [neop] 0.00476485706556
Cases [ftcn] 0.00460307085788
treatment [ftcn] 0.00456491918351
HCC [neop] 0.00454103388438
resection [topp] 0.00443786997025
YEAR [tmco] 0.00431512738037
Hepatectomy [topp] 0.00412198698565
Human [humn] 0.00401456554841
HEPATITIS B VIRUS [virs] 0.00397588455519
Related [qlco] 0.00397008307149
YEARS [tmco] 0.00391402089068
Tumors [neop] 0.00373549456427
Increased [qnco] 0.00356470783931
CIRRHOSIS [dsyn] 0.00347342238675
Group [idcn] 0.00324173187091
Women [popg] 0.00322596681057
Intrahepatic [spco] 0.00315808235589
Children [aggp] 0.00298095539126
DIAGNOSIS [fndg] 0.00291091660695
Including [ftcn] 0.0029106488445
Men [popg] 0.00281696522265
Higher [qlco] 0.00280205480992
Liver Cancer [neop] 0.00279566951558
Conclusions [idcn] 0.00279546309342
Observed [ftcn] 0.00270632317135
Examined [fndg] 0.00261200354657
Mortality [qnco] 0.0025539672604
CT [geoa] 0.00252626748984
Compared [acty] 0.00252015299277
included [ftcn] 0.00249962109575
Important [qlco] 0.00248911792047
Survival [acty] 0.00244666373417
Young [tmco] 0.00237716620039
Groups [idcn] 0.00229389467248
topic9
CIRRHOSIS [dsyn] 0.010450341222
Risk Factors [qnco] 0.00913846128639
Survival [acty] 0.00773930449721
Study [mnob] 0.00726725285347
Odds Ratio [qnco] 0.00697785491083
Human [humn] 0.0063072994302
Hepatocellular Carcinomas [neop] 0.00573293401467
Suggest [idcn] 0.00512541594513
Cases [ftcn] 0.00454494194707
resection [topp] 0.00454194701956
Transplantation [topp] 0.0042822880886
Group [idcn] 0.00412060602228
YEAR [tmco] 0.00409036382216
Conclusions [idcn] 0.00376745770208
Tumors [neop] 0.00364884096526
Cirrhotic [qlco] 0.0036339210888
YEARS [tmco] 0.00356186934709
Increased [qnco] 0.00354505346336
Tumour NOS [neop] 0.00345231503905
Hypermethylation [genf] 0.00329033444271
HEPATITIS C VIRUS [virs] 0.00328838875087
Methods [inpr] 0.00317562869244
LIVER CIRRHOSIS [dsyn] 0.00305119145135
p16 [gngm] 0.00303819954963
chemoembolisation [topp] 0.00302160580054
Arterial [bpoc] 0.00297253509515
Related [qlco] 0.00283786896586
Liver Transplantation [topp] 0.00277835069414
liver resection [topp] 0.00277494853117
LIVER [bpoc] 0.00274955035563
SMALL [qnco] 0.00273120769029
Disease-Free Survival [qnco] 0.00270485952492
Methylation [moft] 0.00266087317749
Performed [ftcn] 0.00257763138032
Chronic hepatitis C [dsyn] 0.00257361514808
Compared [acty] 0.00256700522586
Invasion [fndg] 0.00252393573271
treatment [ftcn] 0.00248235630616
Pathology [bmod] 0.00247601244524
Independent [idcn] 0.00247347013825
